Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Westermark
Giampaolo Merlini

Showing results (41-50 of 585) with videos related to

Pageof 59
Sort By:
Expert Review of Hematology|April 6, 2012
Risk stratification in Waldenström macroglobulinemiaPierre Morel, Giampaolo Merlini
Mayo Clinic Proceedings|November 6, 2018
Seek and You Shall Find: Is Subclinical Amyloid More Common Than Expected?Laura Obici, Giampaolo Merlini
Autoimmunity Reviews|August 11, 2012
Amyloidosis in autoinflammatory syndromesLaura Obici, Giampaolo Merlini
Contributions to Nephrology|November 1, 2006
Mechanisms of renal damage in plasma cell dyscrasias: an overviewGiampaolo Merlini, Claudio Pozzi
Proteomics|February 2, 2018
Proteomics with Mass Spectrometry Imaging: Beyond Amyloid TypingFrancesca Lavatelli, Giampaolo Merlini
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 2, 2012
Myeloma kidney: advances in molecular mechanisms of acute kidney injury open novel therapeutic opportunitiesAndrew Davenport, Giampaolo Merlini
Leukemia|August 26, 2020
Redirecting proteoxicityMario Nuvolone, Giampaolo Merlini
Clinical Chemistry and Laboratory Medicine|January 27, 2016
Free light chain testing for the diagnosis, monitoring and prognostication of AL amyloidosisPeter Mollee, Giampaolo Merlini
Expert Opinion on Therapeutic Targets|October 28, 2017
Emerging therapeutic targets currently under investigation for the treatment of systemic amyloidosisMario Nuvolone, Giampaolo Merlini
Swiss Medical Weekly|June 2, 2012
AA amyloidosis: basic knowledge, unmet needs and future treatmentsLaura Obici, Giampaolo Merlini
Pageof 59

Showing results (41-50 of 585) with videos related to

Sort By:
Pageof 59
Expert Review of Hematology|April 6, 2012
Risk stratification in Waldenström macroglobulinemiaPierre Morel, Giampaolo Merlini
Mayo Clinic Proceedings|November 6, 2018
Seek and You Shall Find: Is Subclinical Amyloid More Common Than Expected?Laura Obici, Giampaolo Merlini
Autoimmunity Reviews|August 11, 2012
Amyloidosis in autoinflammatory syndromesLaura Obici, Giampaolo Merlini
Contributions to Nephrology|November 1, 2006
Mechanisms of renal damage in plasma cell dyscrasias: an overviewGiampaolo Merlini, Claudio Pozzi
Proteomics|February 2, 2018
Proteomics with Mass Spectrometry Imaging: Beyond Amyloid TypingFrancesca Lavatelli, Giampaolo Merlini
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 2, 2012
Myeloma kidney: advances in molecular mechanisms of acute kidney injury open novel therapeutic opportunitiesAndrew Davenport, Giampaolo Merlini
Leukemia|August 26, 2020
Redirecting proteoxicityMario Nuvolone, Giampaolo Merlini
Clinical Chemistry and Laboratory Medicine|January 27, 2016
Free light chain testing for the diagnosis, monitoring and prognostication of AL amyloidosisPeter Mollee, Giampaolo Merlini
Expert Opinion on Therapeutic Targets|October 28, 2017
Emerging therapeutic targets currently under investigation for the treatment of systemic amyloidosisMario Nuvolone, Giampaolo Merlini
Swiss Medical Weekly|June 2, 2012
AA amyloidosis: basic knowledge, unmet needs and future treatmentsLaura Obici, Giampaolo Merlini
Pageof 59